Sign in

CIK 0001628908

  • Large accelerated filer

Evolent Health, Inc.

Sign in to watch
Ticker
EVH
Exchange
NYSE
Industry
Services-Management Services
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
320454912
Phone
+1 571-389-6000
Business address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON, VA, 22209
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$329,460
in 1 filing, $329K under 10b5-1 plans

Net −$329,460. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. McCarthy Daniel Joseph −$329K PRESIDENT sold 9% of stake

Reading 74 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-06-28 TPG Growth II Advisors, Inc. 10% owner Conversion · Class B Units and Class B Common Stock −3,619,531 659,970
2017-06-15 Blackley Seth President Sale −15,000 $25.22 $378K 402,205
2017-06-12 McGrane Nicholas Chief Financial Officer Exercise or conversion +1,667 $3.84 $6K 33,256
2017-06-12 McGrane Nicholas Chief Financial Officer Sale −1,567 $24.53 $38K 31,689
2017-06-12 McGrane Nicholas Chief Financial Officer Sale −100 $25.40 $3K 31,589
2017-06-12 McGrane Nicholas Chief Financial Officer Exercise or conversion · Class A Common Stock Option (right to buy) −1,667 211,285
2017-06-08 Felt Bruce C. Jr. Director Grant or award +4,570 15,825
2017-06-08 Payson Norman Director Grant or award +4,570 15,825
2017-06-08 Farner David Director Grant or award +4,570 15,825
2017-06-08 Scott Cheryl Director Grant or award +4,570 10,943
2017-06-08 D'Amato Michael Director Grant or award +4,570 22,753
2017-06-08 Holder Diane Director Grant or award +4,570 15,825
2017-06-08 SAMET KENNETH A Director Grant or award +4,570 12,420
2017-06-07 McGrane Nicholas Chief Financial Officer Exercise or conversion +10,000 $3.84 $38K 41,589
2017-06-07 McGrane Nicholas Chief Financial Officer Sale −10,000 $27.01 $270K 31,589
2017-06-07 McGrane Nicholas Chief Financial Officer Exercise or conversion · Class A Common Stock Option (right to buy) −10,000 212,952
2017-06-06 McGrane Nicholas Chief Financial Officer Sale −495 $25.75 $13K 31,589
2017-06-06 SAMET KENNETH A Director Sale −4,000 $25.75 $103K 7,850
2017-06-06 WIGGINTON STEVE CEO, Valence Health Sale −959 $25.75 $25K 12,411
2017-06-01 Stone Lydia Principal Accounting Officer Sale −887 $22.95 $20K 9,587

Page 30 of 32 · 627 trades